Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Pituitary Neoplasms 3Neoplasms 2Liver Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Lung Neoplasms 1Kidney Neoplasms 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Chronic Pain 1Agnosia 1Abdominal Neoplasms 1Abdominal Cancer Surgery 1Abdominal Cancer Surgeries 1

Interventions

Fentanyl 9Acetaminophen 5Zoledronic Acid 4Oxycodone 4Ketamine 4Bupivacaine 4Sufentanil 3Hydromorphone 3Diclofenac 3Ropivacaine 2Pregabalin 2Morphine 2Ketorolac 2Ibuprofen 2Ibandronic Acid 2Esketamine 2Epinephrine 2naloxegol 1chloroprocaine 1acetaminophen, aspirin, caffeine drug combination 1Varenicline 1Uterine Artery Embolization 1Ultracet 1Therapeutics 1Propofol 1Pamidronate 1Oxygen 1Nitrous Oxide 1Naproxen 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pain × Dexmedetomidine × Clear all
NCT04029467 2021-02-23

Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery

Lebanese American University

Phase 4 Unknown
44 enrolled
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡